首页|NLR、LMR、PLR及CAR预测广泛期小细胞肺癌患者预后的价值

NLR、LMR、PLR及CAR预测广泛期小细胞肺癌患者预后的价值

扫码查看
目的:探讨中性粒细胞-淋巴细胞比值(NLR)、淋巴细胞-单核细胞比值(LMR)、血小板-淋巴细胞比值(PLR)及C反应蛋白-白蛋白比值(CAR)预测小细胞肺癌患者预后的价值.方法:选取2020年10月至2022年6月在武汉科技大学附属孝感市中心医院诊治的46例局限期小细胞肺癌患者作为局限期组,52例转移小细胞肺癌患者作为广泛期组进行了回顾性分析.对纳入的98例患者中根据是否出现死亡患者,分为死亡组和生存组.收集并分析临床资料、血常规检查.结果:广泛期组NLR、LMR、PLR及CAR值高于局限期组的水平(P<0.05),生存组NLR、LMR、PLR及CAR值低于死亡组(P<0.05);生存组和死亡组在TNM分期、淋巴结转移、远处转移等方面比较差异有统计学意义(P<0.05).结论:广泛期肺癌患者血清NLR、LMR、PLR及CAR水平高于局限期组,可为临床工作中预测小细胞肺癌预后提供参考.
Prognostic value of NLR,LMR,PLR,and CAR in patients with extensive-stage small cell lung cancer
Objective:To investigate the prognostic value of neutrophil-lymphocyte ratio(NLR),lymphocyte-monocyte ratio(LMR),platelet-lymphocyte ratio(PLR),and C-reactive protein-albumin ratio(CAR)in patients with small cell lung cancer.Methods:A total of 46 patients with non-metastatic small-cell lung cancer treated in Xiaogan Central Hospital Affiliated to Wuhan Univer-sity of Science and Technology from October 2020 to June 2022 were selected for retrospective analy-sis as the limited-stage group,and 52 patients with metastatic small-cell lung cancer were included as the extensive-stage group.All the 98 patients were also categorized into death group and survival group according to their outcome.Clinical data and routine blood tests were collected and analyzed.Results:The values of NLR,LMR,PLR,and CAR in the lung cancer group were higher than those in the control group(P<0.05),while the values of NLR,LMR,PLR,and CAR in death group were lower than those in death group(P<0.05).There were significant differences in the TNM stage,lymph node metastasis and distant metastasis between the death group and survival group(P<0.05).Conclusion:The serum levels of NLR,LMR,PLR,and CAR in patients with distant met-astatic lung cancer were higher than those in the control group,which can provide reference for predict-ing the prognosis of small cell lung cancer in clinical work.

Small Cell Lung CancerNeutrophil-Lymphocyte RatioLymphocyte-Monocyte RatioPlatelet-Lymphocyte RatioC-Reactive Protein-Albumin Ratio

马文雯、彭清臻

展开 >

武汉科技大学附属孝感市中心医院 湖北 孝感 432000

小细胞肺癌 中性粒细胞-淋巴细胞比值 淋巴细胞-单核细胞比值 血小板-淋巴细胞比值 C反应蛋白-白蛋白比值

2024

武汉大学学报(医学版)
武汉大学

武汉大学学报(医学版)

CSTPCD
影响因子:0.959
ISSN:1671-8852
年,卷(期):2024.45(6)
  • 1